Fumio Kinoshita

Kyushu University

Papers

2

Total Citations

16

H-Index

2

About

Fumio Kinoshita is a leading urologic oncologist whose research focuses on improving surgical outcomes for prostate cancer patients, particularly through robot-assisted radical prostatectomy (RARP). His work centers on two critical areas: understanding the impact of extended pelvic lymph node dissection (ePLND) on postoperative recovery, and developing predictive tools for cancer recurrence. In his highly cited 2022 study, Kinoshita demonstrated that ePLND significantly correlates with early-phase urinary incontinence after RARP, providing crucial insights for surgical planning and patient counseling. This work, with 9 citations, has helped refine postoperative care protocols. Additionally, Kinoshita developed a novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy, a tool that has garnered 7 citations for its clinical utility in personalizing follow-up strategies. His contributions bridge the gap between surgical technique and long-term oncologic outcomes, offering evidence-based guidance for urologists worldwide. By quantifying risks and improving prediction models, Kinoshita empowers clinicians to optimize treatment decisions for men with prostate cancer, ultimately enhancing both cancer control and quality of life.

Research Focus

Key Achievements

2
H-Index
2
Papers
16
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot‐assisted radical prostatectomy
9 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Kyushu University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago